David F. Hoffmeister, Chief Financial Officer at INVITROGEN CORP (IVGN), sold 27,909 shares at $94.89 ($2.6M) on 2007-12-17, disclosed to the SEC on 2007-12-17.
Open-market sale of $2.6M IVGN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.78 | 1,900 | $180K | 6.8% |
| 2 | $94.81 | 2,600 | $247K | 9.3% |
| 3 | $94.82 | 5,009 | $475K | 17.9% |
| 4 | $94.83 | 900 | $85K | 3.2% |
| 5 | $94.84 | 300 | $28K | 1.1% |
| 6 | $94.85 | 1,300 |
| $123K |
| 4.7% |
| 7 | $94.86 | 400 | $38K | 1.4% |
| 8 | $94.86 | 4,600 | $436K | 16.5% |
| 9 | $94.87 | 1,300 | $123K | 4.7% |
| 10 | $94.88 | 300 | $28K | 1.1% |
| 11 | $94.88 | 700 | $66K | 2.5% |
| 12 | $94.89 | 300 | $28K | 1.1% |
| 13 | $94.90 | 2,000 | $190K | 7.2% |
| 14 | $94.91 | 300 | $28K | 1.1% |
| 15 | $94.92 | 1,800 | $171K | 6.5% |
| 16 | $94.93 | 500 | $47K | 1.8% |
| 17 | $94.94 | 100 | $9K | 0.4% |
| 18 | $94.95 | 700 | $66K | 2.5% |
| 19 | $94.97 | 2,600 | $247K | 9.3% |
| 20 | $94.98 | 300 | $28K | 1.1% |
| Total | $94.87 avg | 27,909 | $2.6M | 100% |
| Filing → |
| LIFE | SELL | 2009-09-16 | $9.2M | — | Filing → |